Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington. The company trades on NMS exchange. The company headquarter is located in Vancouver ,United States.

TickerABSI
Long NameAbsci Corporation
Short NameAbsci Corporation